Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation

Journal of Intellectual Disability Research

Volumn 40, Issue 6, 1996, Pages 509-517

  Castells, S ^a   Beaulieu, I ^a   Torrado, C ^a   Wisniewski, K E ^a   Zarny, S ^a   Gelato, M C ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; LEVODOPA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HUMAN; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRESCHOOL CHILD;

EID: 0030457465     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2788.1996.tb00661.x     Document Type: Article

References (64)

1. Annerén G., Carlsson-Skwirut C., Gustafsson J., Tuvemo T. & Sara R. (1993) Growth retardation in children with Down's syndrome in relation to insulin-like growth factors and growth hormone therapy. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 182-98. John Wiley and Sons, Chichester.
2. Benda C. E. (1939) Studies in mongolism. I. Growth and physical development. Archives of Neurology and Psychiatry 41, 83-97.
3. Benda C. E. (1960) The Child with Mongolism (Congenital Acromicna). Grune and Stratton; New York, NY.
4. Böhlen P., Brazeau P., Bloch B., Ling N., Gaillard R. & Guillemin R. (1983) Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochemistry and Biophysics Research Communications 114, 930-6.
5. Castells S., Torrado C., Bastian W. & Wisniewski K. E. (1992) Growth hormone deficiency in Down's syndrome children. Journal of Intellectual Disability Research 36, 29-43-
6. Castells S., Beaulieu I. & Wisniewski K. E. (1993) Long-term effects of recombinant human growth hormone (rhGH) on children with Down's syndrome with short stature. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 163-82. John Wiley and Sons, Chichester.
7. Cavero I. & Roach A. G. (1978) The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks. British Journal of Pharmacology 62, 468P-9P.
8. Chatelain P., Alamercery Y., Blanchard J., Boissel J. P., Evain-Brion D., Morre M., Olivier M., Sizonenko P. & Van Vliet G. (1987) Growth hormone (GH) response to a single intravenous injection of synthetic GH-releasing hormone in prepubertal children with growth failure. Journal of Clinical Endocrinology and Metabolism 65, 387-94.
9. Chen A. T., Sergovich F. R., McKim J. S., Barr M. L. & Gruber D. (1970) Chromosome studies in full-term low-birth-weight, mentally retarded patients. Journal of Pediatrics 76, 393-8.
10. Chihara K., Kashio Y., Kita T., Okimura Y., Kaji H., Abe H. & Fujita T. (1986) L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. Journal of Clinical Endocrinology and Metabolism 62, 466-73.
11. Clark R. G. & Robinson I. C. A. F. (1985) Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats. Nature 314, 281-3.
12. Crino A., Ciampalini P., Digilio M. C., Obregon M. G., Giannotti A. & Borrelli P. (1993) Abnormal thyrotropin secretion in Down's syndrome. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 101-9. John Wiley and Sons, Chichester.
13. Cronk C. E. & Pueschel S. M. (1984) Anthropometric studies. In: The Young Child with Down Syndrome (ed. S. M. Pueschel), pp. 105-41. Human Sciences Press, New York, NY.
14. Cronk C. E., Crocker A. C., Pueschel S. M., Shea A. M., Zackai E., Pickens G. & Reed R. B. (1988) Growth charts of children with Down syndrome: 1 month to 18 years of age. Pediatrics 81, 102-10.
15. Cronk C. E. (1993) Growth retardation in Down's syndrome. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 13-30. John Wiley and Sons, Chichester.
16. Donnadieu M., Evain-Brion D., Tonon M. C., Vaudry H. & Job J. C. (1985) Variations of plasma growth hormone (GH)-releasing factor levels during GH stimulation tests in children. Journal of Clinical Endocrinology and Metabolism 60, 1132-4.
17. Drew G. M., Gower A. J. & Marriott A. S. (1979) Alpha 2-adrenoceptors mediate clonidine-induced sedation in the rat. British Journal of Pharmacology 67, 133-41.
18. Ershow A. G. (1986) Growth in black and white children with Down syndrome. American Journal of Mental Deficiency 90, 507-12.
19. Gelato M. C., Pescovitz O., Cassorla F., Loriaux D. L. & Merriam G. R. (1983) Effects of a growth hormone releasing factor in man. Journal of Clinical Endocrinology and Metabolism 57, 674-6.
20. Gelato M. C., Pescovitz O. H., Cassorla F., Loriaux D. L. & Merriam G. R. (1984) Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women. Journal of Clinical Endocrinology and Metabolism 59, 197-201.
21. Gelato M. C., Rittmaster R. S., Pescovitz O. H., Nicoletti M. C., Nixon W. E., D'Agata R., Loriaux D. L. & Merriam G. R. (1985) Growth hormone responses to continuous infusions of growth hormone-releasing hormone. Journal of Clinical Endocrinology and Metabolism 61, 223-8.
22. Gelato M. C., Malozowski S., Caruso-Nicoletti M., Ross J. L., Pescovitz O. H., Rose S., Loriaux D. L., Cassorla F. & Merriam G. R. (1986) Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency. Journal of Clinical Endocrinology and Metabolism 63, 174-9.
23. Greulich W. W. & Pyle S. I. (1959) Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford University Press, Stanford, CA.
24. Hassold T. J. & Jacobs P. A. (1984) Trisomy in man. Annual Review of Genetics 18, 69-97.
25. Hernández M., Sánchez E., Sobradillo B., Rincón J. M. & Narvaiza J. L. (1988) A new method for assessment of skeletal maturity in the first 2 years of life. Pediatric Radiology 18, 484-9.
26. Jaswal S. & Jaswal I. J. S. (1981) An anthropometric study of body size in Down syndrome. Indian Journal of Pediatrics 48, 81-4.
27. Katz C. M. & Taylor P. M. (1967) The incidence of low birth weight in children with severe mental retardation. American Journal of Diseases of Childhood 114, 80-7.
28. Kucera J. (1971) Indirect evidence for normal fetoplacental function in Down's syndrome. Obstetrics and Gynecology 38, 551-4.
29. Lin H. D., Bollinger J., Ling N. & Reichlin S. (1984) Immunoreactive growth hormone-releasing factor in human stalk median eminence. Journal of Clinical Endocrinology and Metabolism 58, 1197-9.
30. Ling N., Zeytin F., Böhlen P., Esch F., Brazeau P., Wehrenberg W. B., Baird A. & Guillemin R. (1985) Growth hormone releasing factors. Annul Review of Biochemistry 54, 403-23.
31. Luzuriaga C., Garcia L. V. & Flórez J. (1993) Growth characteristics in prepubertal children with Down's syndrome in Cantabria, Spain. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewsta), pp. 33-6. John Wiley and Sons, Chichester.
32. Mayo K. E., Cerelli G. M., Lebo R. V., Bruce B. D., Rosenfeld M. G. & Evans R. M. (1985) Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. Proceedings of the National Academy of Sciences, USA 82, 63-7.
33. Miki N., Ono M. & Shizume K. (1984) Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone releasing factor (GRF). Endocrinology 114, 1950-2.
34. Murdoch J. C., Gray C. A., McLarty D. G. & Ratcliffe J. G. (1978) Pituitary function in Down's syndrome. Journal of Mental Deficiency Research 22, 273-5.
35. National Center for Health Statistics (1977) NCHS growth curves for children, birth to 18 years. Health examination survey, children and youths, no. 165, (US) National Center for Health Statistics, Hyattsville, MD.
36. Palmer C. G. S., Cronk C., Pueschel S. M., Wisniewski K. E., Laxova R., Crocker A. C. & Pauli R. M. (1992) Head circumference of children with Down syndrome (0-36 months). American Journal of Medical Genetics 42, 61-7.
37. Pueschel S. M. (1990) Growth, thyroid function, and sexual maturation in Down syndrome. Growth Genetics and Hormones 6, 1-5.
38. Ragusa L., Romano C., Failla P., Proto C. & Colabucci F. (1992) Growth hormone subnormally in Down's syndrome [letter]. American Journal of Medical Genetics 43, 894-5.
39. Ragusa L., Alberti A., Proto C., Romano C. & Colabucci F. (1993) Preliminary results after one year of recombinant human growth hormone treatment in four subjects with Down's syndrome. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 199-202. John Wiley and Sons, Chichester.
40. Ranke M. B. (1986) Clinical experience with GRF. Acta Paediatrica Scandinavica (Suppl) 325, 100-6.
41. Rarick G. L. & Seefeldt V. (1974) Observations from longitudinal data on growth in stature and sitting height of children with Down's syndrome. Journal of Mental Deficiency Research 18, 63-78.
42. Reichlin S. (1960) Growth and the hypothalamus. Endocrinology 67, 760-73.
43. Reichlin S. (1961) Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69, 225-30.
44. Reid J. L., Tangri K. K. & Wing L. M. N. (1977) The central hypotensive action of clonidine and propranolol in animals and man. Progress in Brain Research 47, 369-83.
45. Rivier J., Spiess J. & Vale W. (1983) Human and rat hypothalamic growth hormone releasing factor (GRF). In: Peptides, Structure and Function. Proceedings of the 8th American Peptide Symposium, University of Arizona (eds V. J. Hubry & D. H. Rich), pp. 853-6. Pierce Chemical Co., Rockford, IL.
46. Rochiccioli P. E., Tauber M.-T., Uboldi F., Coude F.-X. & Morre M. (1986) Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency. Journal of Clinical Endocrinology and Metabolism 63, 1100-5.
47. Rogol A. D., Blizzard R. M., Johanson A. J., Furlanetto R. W., Evans W. S., Rivier J., Vale W. W. & Thorner M. O. (1984) Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. Journal of Clinical Endocrinology and Metabolism 59, 580-6.
48. Schmitt H., Schmitt H. & Fenard S. (1971) Evidence for an alpha- sympathomiraetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. European Journal of Pharmacology 14, 98-100.
49. Schriock E. A., Hulse J. A., Harris D. A., Kaplan S. L. & Grumbach M. M. (1987) Evaluation of hypothalamic dysfunction in growth hormone (GH)-deficient patients using single vs. multiple doses of GH-releasing hormone (GHRH-44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 65, 1177-82.
50. Sharav T. (1993) Thyroid dysfunction and growth retardation in Down's syndrome. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 73-91. John Wiley and Sons, Chichester.
51. Takano K., Hizuka N., Shizume K., Asakawa K., Miyakawa M., Hirose N., Shibasaki T. & Ling N. C. (1984) Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. Journal of Clinical Endocrinology and Metabolism 58, 236-41.
52. Tapanainen P., Knip M., Lautala P. & Leppäluoto J. (1988) Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. Journal of Clinical Endocrinology and Metabolism 67, 845-9.
53. Thorner M. O., Reschke J., Chitwood J., Rogol A. D., Furlanetto R., Rivier J., Vale W. & Blizzard R. M. (1985) Acceleration of growth in two children treated with human growth hormone-releasing factor. New England Journal of Medicine 312, 4-9.
54. Timmerrnans P. B., Lam E. & Van Zwieten P. A. (1979) The interaction between prazosin and clonidine at alpha-adrenoceptors in rats and cats. European Journal of Pharmacology 55, 57-66.
55. Torrado C., Bastian W., Wisniewski K. E. & Castells S. (1991) Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. Journal of Pediatrics 119, 478-83.
56. Torrado C. & Castells S. (1993) Diagnosis of hypothalamic dysfunction in Down's syndrome producing growth hormone deficiency. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 55-71. John Wiley and Sons, Chichester.
57. Watson E. H. & Lowery G. H. (1962) Growth and Development of Children, 4th edn. Year Book Medical Publishers, Chicago, IL.
58. Webb C. B., Vance M. L., Thorner M. O., Perisutti G., Thominet J., Rivier J., Vale W. & Frohman L. A. (1984) Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation. Journal of Clinical Investigation 74, 96-103.
59. Wisniewski K. E., Laure-Kamionowska M. & Wisniewski H. M. (1984) Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome [letter]. New England Journal of Medicine 311, 1187-8.
60. Wisniewski K. E., Laure-Kamionowska M., Connell F. & Wen G. Y. (1986) Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down syndrome. In: The Neurobiology of Down Syndrome (ed. C. J. Epstein), pp. 29-44. Raven Press, New York, NY.
61. Wisniewski K. E. (1990) Down syndrome children often have brain with maturation delay, retardation of growth and cortical dysgenesis. American Journal of Medical Genetics (Suppl.) 7, 274-81.
62. Wisniewski K. E. & Bobinski M. (1991) Hypothalamic abnormalities in Down syndrome. In: The Morphogenesis of Down Syndrome (ed. C. J. Epstein), pp. 153-67. Progress in Clinical and Biological Research 373. Wiley-Liss, New York, NY.
63. Wisniewski K. E., Beaulieu I., Bobinski M., Lee M. H. & Castells S. (1993) Microcephaly and neurological and neuropathological abnormalities in children with Down's syndrome. In: Growth Hormone Treatment in Down's Syndrome (eds S. Castells & K. E. Wisniewski), pp. 37-54. John Wiley and Sons, Chichester.
64. Wurtman R. (1970) Brain catecholamines and the control of secretion from the anterior pituitary gland. In: Hypophystotropic Hormones of the Hypothalamus: Assay and Chemistry (ed. J. Meites), pp. 184-94. Williams and Wilkins, Baltimore, MD.